You're reading the free version. Trader adds the live tape and alerts.
Start tracking
NVCT Buy Disclosure
Bentsur Ron · SEC Form 4 · Filed Jul 1, 2026
Buy
Calculated transaction value
$250K
Bentsur Ron Chairman & CEO
NVCT
Nuvectis Pharma
NVCT
Transaction date
Jun 30, 2026
Public filing date
Jul 1, 2026
Filing lag
Filed 1 day later
NVCT daily price context
Close on/before transaction
$18.39
Jun 30, 2026
First close after public filing
$19.57
Jul 2, 2026
30-day return after filing
+9.96%
Through Jul 31, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 12,500 shares @ $20
- SEC ownership
- Direct
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001104659-26-079792
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$250K
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Nuvectis Pharma, Inc. NVCT Current | Buy | Jun 30, 2026 | $250K |